Activity cliffs in drug discovery: Dr Jekyll or Mr Hyde?

M Cruz-Monteagudo, JL Medina-Franco… - Drug Discovery …, 2014 - Elsevier
Highlights•We provide a critical review of the current state of the activity cliff research.•We
comment on and integrate the opinions of experts working on activity cliffs.•The negative …

On exploring structure–activity relationships

R Guha - In silico models for drug discovery, 2013 - Springer
Understanding structure–activity relationships (SARs) for a given set of molecules allows
one to rationally explore chemical space and develop a chemical series optimizing multiple …

Exploring activity cliffs in medicinal chemistry: miniperspective

D Stumpfe, J Bajorath - Journal of medicinal chemistry, 2012 - ACS Publications
In recent years, structure− activity relationships (SARs) have increasingly been studied
through mining of large compound data sets, leading to a renaissance of the activity …

Expanding the medicinally relevant chemical space with compound libraries

F López-Vallejo, MA Giulianotti, RA Houghten… - Drug discovery today, 2012 - Elsevier
Analysis of marketed drugs and commercial vendor libraries used in high-throughput
screening suggests that the medicinally relevant chemical space may be expanded to …

Predicting protein-ligand interactions based on bow-pharmacological space and Bayesian additive regression trees

L Li, CC Koh, D Reker, JB Brown, H Wang, NK Lee… - Scientific reports, 2019 - nature.com
Identifying potential protein-ligand interactions is central to the field of drug discovery as it
facilitates the identification of potential novel drug leads, contributes to advancement from …

Scanning Structure–Activity Relationships with Structure–Activity Similarity and Related Maps: From Consensus Activity Cliffs to Selectivity Switches

JL Medina-Franco - Journal of chemical information and modeling, 2012 - ACS Publications
Systematic description of structure–activity relationships (SARs) of data sets and structure–
property relationships (SPRs) is of paramount importance in medicinal chemistry and other …

Simplified, interpretable graph convolutional neural networks for small molecule activity prediction

JK Weber, JA Morrone, S Bagchi, JDE Pabon… - Journal of Computer …, 2022 - Springer
We here present a streamlined, explainable graph convolutional neural network (gCNN)
architecture for small molecule activity prediction. We first conduct a hyperparameter …

Chemoinformatics: a view of the field and current trends in method development

M Vogt, J Bajorath - Bioorganic & medicinal chemistry, 2012 - Elsevier
The chemoinformatics field continues to evolve at the interface between computer science
and chemistry. Chemical information and computational approaches in pharmaceutical …

Towards the understanding of the activity of G9a inhibitors: an activity landscape and molecular modeling approach

E López-López, O Rabal, J Oyarzabal… - Journal of Computer …, 2020 - Springer
In this work, we analyze the structure–activity relationships (SAR) of epigenetic inhibitors
(lysine mimetics) against lysine methyltransferase (G9a or EHMT2) using a combined …

Design and Diversity analysis of chemical libraries in drug discovery

DA Olmedo, AA Durant-Archibold… - … chemistry & high …, 2024 - ingentaconnect.com
Chemical libraries and compound data sets are among the main inputs to start the drug
discovery process at universities, research institutes, and the pharmaceutical industry. The …